RVMD Revolution Medicines, Inc.
RVMD Revolution Medicines, Inc.
Healthcare · Biotechnology
Market read
Scan convergence 1 scan as of 2026-10-16 1 neutral converging
POC $96.52 · VWAP $132.01 · +34.8% vs 12m avg buyer
Insiders selling 0 buy / 4 sell · Form 4, 90d $60M sold last open-market sell Kelsey Stephen Michael
Cluster CFO, COO + 6 others sold $11.3M, Sep 18–Oct 1
Coverage
1 watchlist
RVMD Price Structure
Loading timeframes…
Peers
Every watchlist RVMD belongs to, members best 30-day change first — RVMD highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@ibb
Reported the quarter ending 2026-06-30: diluted EPS -$3.06, net income -$644M (SEC filing). Across the print the stock moved +2.2% (close before → first close after).
full note →Against street estimates
How RVMD's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
RVMD research tape
58 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.